Clinical Trial Update: Melphalan 200 mg/m2 Versus Melphalan 100 mg/m2 in Newly Diagnosed Myeloma Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing high-dose versus standard-dose melphalan in newly diagnosed multiple myeloma patients has completed enrollment with status listed as com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Melphalan (Melphalan)

Snippet

Sponsor: Azienda Ospedaliera San Giovanni Battista | Conditions: Multiple Myeloma, Diagnosis | Phase 3 | Status: COMPLETED